These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 206349)

  • 41. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
    Gunvén P; Klein G; Henle G; Henle W; Clifford P
    Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
    [No Abstract]   [Full Text] [Related]  

  • 42. Immune response to different sequences of the EBNA I molecule in Epstein-Barr virus-related disorders and in autoimmune diseases.
    Marchini B; Dolcher MP; Sabbatini A; Klein G; Migliorini P
    J Autoimmun; 1994 Apr; 7(2):179-91. PubMed ID: 7518683
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Smooth muscle antibody in Burkitt's lymphoma and in nasopharyngeal carcinoma.
    Lamelin JP; Williams EH; Souissi T; De-Thé G; Gabbiani G
    Clin Exp Immunol; 1977 Apr; 28(1):157-62. PubMed ID: 193662
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Down-regulation of integrated Epstein-Barr virus nuclear antigen 1 and 2 genes in a Burkitt lymphoma cell line after somatic cell fusion with autologous EBV-immortalized lymphoblastoid cells.
    Wolf J; Pawlita M; Klevenz B; Frech B; Freese UK; Müller-Lantzsch N; Diehl V; zur Hausen H
    Int J Cancer; 1993 Feb; 53(4):621-7. PubMed ID: 8382194
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes.
    Schaefer BC; Woisetschlaeger M; Strominger JL; Speck SH
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6550-4. PubMed ID: 1713681
    [TBL] [Abstract][Full Text] [Related]  

  • 46. V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma.
    Zhang XS; Wang HH; Hu LF; Li A; Zhang RH; Mai HQ; Xia JC; Chen LZ; Zeng YX
    Cancer Lett; 2004 Jul; 211(1):11-8. PubMed ID: 15194212
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Interaction between Epstein-Barr virus-determined nuclear antigen (EBNA) and the viral DNA.
    Gergely L; Luka J; Klein G
    J Gen Virol; 1984 Nov; 65 ( Pt 11)():2043-8. PubMed ID: 6094716
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New type B isolates of Epstein-Barr virus from Burkitt's lymphoma and from normal individuals in endemic areas.
    Young LS; Yao QY; Rooney CM; Sculley TB; Moss DJ; Rupani H; Laux G; Bornkamm GW; Rickinson AB
    J Gen Virol; 1987 Nov; 68 ( Pt 11)():2853-62. PubMed ID: 2824665
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T cell recognition of Epstein-Barr virus associated lymphomas.
    Rickinson AB; Murray RJ; Brooks J; Griffin H; Moss DJ; Masucci MG
    Cancer Surv; 1992; 13():53-80. PubMed ID: 1330300
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between clinical stage, histopathology and antibody titers against the second Epstein-Barr virus nuclear antigen (EBNA-2) in non-Hodgkin's lymphoma patients.
    Masucci G; Mellstedt H; Henle G; Henle W; Rymo L; Masucci MG; Ernberg I; Klein G
    Int J Cancer; 1989 Jun; 43(6):1017-21. PubMed ID: 2543639
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Frequent association of Epstein-Barr virus in Japanese patients with Burkitt's lymphoma.
    Okano M; Kikuta H; Abo W; Koizumi S; Aya T; Yano S; Takada K; Mizuno F; Osato T
    Jpn J Clin Oncol; 1992 Oct; 22(5):320-4. PubMed ID: 1281896
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relation between Epstein-Barr viral and cell membrane immunofluorescence in Burkitt tumor cells. 3. Comparison of blocking of direct membrane immunofluorescence and anti-EBV reactivities of different sera.
    Klein G; Pearson G; Henle G; Henle W; Goldstein G; Clifford P
    J Exp Med; 1969 Apr; 129(4):697-705. PubMed ID: 4886044
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Detection of Epstein-Barr virus-associated antigen in fine needle aspiration smears from cervical lymph nodes in the diagnosis of nasopharyngeal carcinoma.
    Chan MK; Huang DW; Ho YH; Lee JC
    Acta Cytol; 1989; 33(3):351-4. PubMed ID: 2543173
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Down-regulation of Epstein-Barr virus nuclear antigen 1 in Reed-Sternberg cells of Hodgkin's disease.
    Khan G; Naase MA
    J Clin Pathol; 1995 Sep; 48(9):845-8. PubMed ID: 7490319
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparisons of nuclear antigens of Epstein-Barr virus (EBV) and EBV-like simian viruses.
    Rabin H; Strnad BC; Neubauer RH; Brown AM; Hopkins RF; Mazur RA
    J Gen Virol; 1980 Jun; 48(Pt 2):265-72. PubMed ID: 6156993
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A Danish adult case of EBV-positive Burkitt's lymphoma.
    Laulund S; Elling F; Saemundsen AK
    Acta Pathol Microbiol Immunol Scand A; 1983 Jan; 91(1):77-80. PubMed ID: 6299057
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Detection of a nuclear, EBNA-type antigen in apparently EBNA-negative Herpesvirus papio (HVP)-transformed lymphoid lines by the acid-fixed nuclear binding technique.
    Ohno S; Luka J; Falk L; Klein G
    Int J Cancer; 1977 Dec; 20(6):941-6. PubMed ID: 73523
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Complementary serum test of antibodies to Epstein-Barr virus nuclear antigen-1 and early antigen: a possible alternative for primary screening of nasopharyngeal carcinoma.
    Chang KP; Hsu CL; Chang YL; Tsang NM; Chen CK; Lee TJ; Tsao KC; Huang CG; Chang YS; Yu JS; Hao SP
    Oral Oncol; 2008 Aug; 44(8):784-92. PubMed ID: 18206420
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between Epstein-Barr virus (EBV) DNA and the EBV-determined nuclear antigen (EBNA) in Burkitt lymphoma biopsies and other lymphoproliferative malignancies.
    Lindahl T; Klein G; Reedman BM; Johansson B; Singh S
    Int J Cancer; 1974 Jun; 13(6):764-72. PubMed ID: 4137165
    [No Abstract]   [Full Text] [Related]  

  • 60. Heterogeneity of Epstein-Barr virus derived from P3HR-1 cells.
    zur Hausen H; Fresen KO
    IARC Sci Publ (1971); 1978; (20):391-6. PubMed ID: 215522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.